Martingale Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,400	Closed	-$274K	–	800
2023 Q3	$274K	Hold	1,400	–	–	0.01%	701
2023 Q2	$294K	Hold	1,400	–	–	0.01%	699
2023 Q1	$283K	Sell	1,400 -395	-22%	-$89.5K	0.01%	717
2022 Q4	$391K	Sell	1,795 -752	-30%	-$164K	0.01%	672
2022 Q3	$502K	Sell	2,547 -53,981	-95%	-$11.7M	0.01%	622
2022 Q2	$12.1M	Sell	56,528 -5,086	-8%	-$1.24M	0.22%	129
2022 Q1	$17.5M	Sell	61,614 -6,586	-10%	-$2.03M	0.26%	131
2021 Q4	$25.7M	Sell	68,200 -7,000	-9%	-$2.72M	0.33%	116
2021 Q3	$31M	Sell	75,200 -16,013	-18%	-$6.65M	0.41%	100
2021 Q2	$33.7M	Buy	91,213 +4,899	+6%	+$1.64M	0.39%	99
2021 Q1	$25M	Buy	86,314 +4,370	+5%	+$1.21M	0.29%	124
2020 Q4	$20.5M	Buy	81,944 +34,684	+73%	+$8.26M	0.23%	133
2020 Q3	$10.7M	Buy	47,260 +39,655	+521%	+$8.23M	0.13%	163
2020 Q2	$1.33M	Buy	7,605 +2,600	+52%	+$415K	0.02%	659
2020 Q1	$633K	Buy	+5,005	New	+$751K	0.01%	772